VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02,...
FDA Recall #D-819-2013 — Class II — November 6, 2012
Product Description
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,
Reason for Recall
Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.
Recalling Firm
Alkermes, Inc. — Waltham, MA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
3,325 vials
Distribution
Nationwide
Code Information
Individual vial lot 402-3683AA, EXP 10/13; kit vial lot 2011-003, EXP 08/13
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.